Evidence map›Paper›PMID 34190597›Full record

ArticleJournal of virology2021

Protection of Newborn Macaques by Plant-Derived HIV Broadly Neutralizing Antibodies: a Model for Passive Immunotherapy during Breastfeeding.

Yvonne J Rosenberg, Xiaoming Jiang, Tracy Cheever, Felicity J Coulter, Shilpi Pandey, Markus Sack, Lingjun Mao, Lori Urban, Jonathan Lees, Miranda Fischer and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Yvonne J RosenbergPlantVax Corporation, Rockville, Maryland, USA.
Xiaoming JiangPlantVax Corporation, Rockville, Maryland, USA.
Tracy CheeverOregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Felicity J CoulterDepartment of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, Oregon, USA.
Shilpi PandeyOregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Markus SackPro-SPR GmbH, Alsdorf, Germany.
Lingjun MaoPlantVax Corporation, Rockville, Maryland, USA.
Lori UrbanPlantVax Corporation, Rockville, Maryland, USA.
Jonathan LeesPlantVax Corporation, Rockville, Maryland, USA.
Miranda FischerOregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Jeremy SmedleyOregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Heather SidenerOregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Jeffrey StantonOregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Nancy L HaigwoodOregon National Primate Research Center, Oregon Health & Science University, Beaverton, Oregon, USA.
Oregon National Primate Research Center · USOregon Health & Science University · US

Funding

Upgrade of confocal microscopy at the Oregon National Primate Research CenterP51OD011092 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Bonnie J. Nagel · 2012 to 2026
$203.9M
Phase 2 Enhancement of Outdoor Group Housing for U42 SPF 9 Rhesus MacaquesU42OD023038 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI RUDOLF Paul BOHM, Lauren Drew Martin · 2016 to 2026
$21.9M
Viral Testing CoreU42OD010426 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI Andrew Haertel, Lauren Drew Martin · 2013 to 2026
$6.0M
Plant-derived HIV neutralizing mAbs for passive immunotherapy in newborn macaquesR44AI081621 · NIAID · PLANTVAX, INC. · PI ROSENBERG, YVONNE J · 2011 to 2017
$3.5M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID) R44-AI081621HHS | NIH | NIH Office of the Director (OD) P51-OD011092HHS | NIH | NIH Office of the Director (OD) U42-OD023038NIAID NIH HHS R44 AI081621NIH HHS P51 OD011092NIH HHS U42 OD010426NIH HHS U42 OD023038
6 · The paper itself

Abstract

Preventing human immunodeficiency virus (HIV) infection in newborns by vertical transmission remains an important unmet medical need in resource-poor areas where antiretroviral therapy (ART) is not available and mothers and infants cannot be treated prepartum or during the breastfeeding period. In the present study, the protective efficacy of the potent HIV-neutralizing antibodies PGT121 and VRC07-523, both produced in plants, were assessed in a multiple-SHIV (simian-human immunodeficiency virus)-challenge breastfeeding macaque model. Newborn macaques received either six weekly subcutaneous injections with PGT121 alone or as a cocktail of PGT121-LS plus VRC07-523-LS injected three times every 2 weeks. Viral challenge with SHIV

Indexed as

Breast FeedingAnimalsAnimals, NewbornBroadly Neutralizing AntibodiesFemaleHIV-1HIV InfectionsImmunization, PassiveLeukocytes, MononuclearMacaca mulattaMaleNicotianaSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency VirusViremiaBroadly Neutralizing Antibodiesbreastfeedinghuman immunodeficiency virusimmunotherapyneutralizing antibodiesnonhuman primate

Identifiers

PMID34190597
PMCPMC8387040
OpenAlexW3176793822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.